Enter your email address:

Delivered by FeedBurner

Cadila, one of India's two Covid vaccine makers, is going in for a huge capacity boost

While Cadila's plasmid DNA candidate doesn't use an infectious agent
like others, and instead introduces the DNA sequence encoding the
antigen, the other tests being done are for traditional delivery
methods. Serum Institute is conducting tests for the candidate
developed by Oxford University. Dr Reddy's plans to distribute the
Russian vaccine.



Post a Comment